0001562180-21-001517.txt : 20210223 0001562180-21-001517.hdr.sgml : 20210223 20210223202649 ACCESSION NUMBER: 0001562180-21-001517 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210211 FILED AS OF DATE: 20210223 DATE AS OF CHANGE: 20210223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hykes Andrew CENTRAL INDEX KEY: 0001806431 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39293 FILM NUMBER: 21668054 MAIL ADDRESS: STREET 1: C/O INARI MEDICAL, INC. STREET 2: 9 PARKER AVENUE, SUITE 100 CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inari Medical, Inc. CENTRAL INDEX KEY: 0001531048 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 452902923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 PARKER, SUITE 100 CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-923-4747 MAIL ADDRESS: STREET 1: 9 PARKER, SUITE 100 CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: Inceptus Newco1 Inc. DATE OF NAME CHANGE: 20110923 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2021-02-11 false 0001531048 Inari Medical, Inc. NARI 0001806431 Hykes Andrew C/O INARI MEDICAL, INC. 9 PARKER, SUITE 100 IRVINE CA 92618 false true false false Chief Operating Officer Common Stock 2021-02-11 4 A false 16030.00 0.00 A 211971.00 D Common Stock 2021-02-19 4 S false 300.00 115.04 D 211671.00 D Common Stock 2021-02-19 4 S false 1501.00 116.4813 D 210170.00 D Common Stock 2021-02-19 4 S false 4672.00 117.6703 D 205498.00 D Common Stock 2021-02-19 4 S false 1507.00 118.6171 D 203991.00 D Common Stock 2021-02-19 4 S false 1020.00 119.3796 D 202971.00 D Common Stock 1550.00 I By Child 1 Common Stock 1550.00 I By Child 2 Common Stock 1550.00 I By Child 3 Common Stock 1000.00 I By Spouse 2021 Annual RSU grant - vesting Commencement date Jan-1-2021, 1/16th of the RSUs shall vest on each quarterly anniversary of the Vesting Commencement Date. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020. This transaction was executed in multiple trades at prices ranging from $116.13 to $116.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $117.25 to $118.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $118.25 to $119.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $119.31 to $119.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Angela Ahmad, attorney-in-fact for Andrew Hykes 2021-02-23